Literature DB >> 20533939

Catastrophic squamous cell carcinoma in lung transplant patients treated with voriconazole.

Sherrif F Ibrahim1, Jonathan P Singer, Sarah T Arron.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20533939      PMCID: PMC3046628          DOI: 10.1111/j.1524-4725.2010.01596.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


× No keyword cloud information.
  9 in total

1.  Skin cancers in organ transplant recipients.

Authors:  Jean Kanitakis; Sylvie Euvrard; Alain Claudy
Journal:  J Am Acad Dermatol       Date:  2006-06       Impact factor: 11.527

2.  Severe photosensitivity causing multifocal squamous cell carcinomas secondary to prolonged voriconazole therapy.

Authors:  Kate L McCarthy; E Geoffrey Playford; David F M Looke; Michael Whitby
Journal:  Clin Infect Dis       Date:  2007-01-23       Impact factor: 9.079

3.  Multifocal squamous cell carcinomas in an HIV-infected patient with a long-term voriconazole therapy.

Authors:  Anne Sophie Brunel; Thibaut Fraisse; Catherine Lechiche; Véronique Pinzani; Jean Marc Mauboussin; Albert Sotto
Journal:  AIDS       Date:  2008-04-23       Impact factor: 4.177

4.  Incidence of skin cancer in 5356 patients following organ transplantation.

Authors:  B Lindelöf; B Sigurgeirsson; H Gäbel; R S Stern
Journal:  Br J Dermatol       Date:  2000-09       Impact factor: 9.302

5.  Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens.

Authors:  P Jensen; S Hansen; B Møller; T Leivestad; P Pfeffer; O Geiran; P Fauchald; S Simonsen
Journal:  J Am Acad Dermatol       Date:  1999-02       Impact factor: 11.527

6.  Multiple aggressive squamous cell carcinomas associated with prolonged voriconazole therapy in four immunocompromised patients.

Authors:  O Epaulard; C Saint-Raymond; C Villier; J Charles; N Roch; J-C Beani; M-T Leccia
Journal:  Clin Microbiol Infect       Date:  2010-09       Impact factor: 8.067

7.  Fatal diffuse alveolar damage in two lung transplant patients treated with cetuximab.

Authors:  Lorriana E Leard; Bryan K Cho; Kirk D Jones; Steven R Hays; Whitney D Tope; Jeffrey A Golden; Charles W Hoopes
Journal:  J Heart Lung Transplant       Date:  2007-12       Impact factor: 10.247

8.  Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole.

Authors:  Edward W Cowen; Josephine C Nguyen; Daniel D Miller; Diana McShane; Sarah T Arron; Neil S Prose; Maria L Turner; Lindy P Fox
Journal:  J Am Acad Dermatol       Date:  2009-11-06       Impact factor: 11.527

9.  Aggressive cutaneous squamous cell carcinoma associated with prolonged voriconazole therapy in a renal transplant patient.

Authors:  A Vanacker; G Fabré; J Van Dorpe; W E Peetermans; B Maes
Journal:  Am J Transplant       Date:  2008-02-05       Impact factor: 8.086

  9 in total
  6 in total

1.  Long-term voriconazole and skin cancer: is there cause for concern?

Authors:  Cornelius J Clancy; M Hong Nguyen
Journal:  Curr Infect Dis Rep       Date:  2011-12       Impact factor: 3.725

2.  Skin cancer in transplant recipients, out of the woods. Scientific retreat of the ITSCC and SCOPE.

Authors:  O R Colegio; E M Billingsley
Journal:  Am J Transplant       Date:  2011-08       Impact factor: 8.086

3.  Voriconazole enhances UV-induced DNA damage by inhibiting catalase and promoting oxidative stress.

Authors:  Vivian Lee; Michael D Gober; Hasan Bashir; Conor O'Day; Ian A Blair; Clementina Mesaros; Liwei Weng; Andrew Huang; Aaron Chen; Rachel Tang; Vince Anagnos; JiLon Li; Sophie Roling; Emilija Sagaityte; Andrew Wang; Chenyan Lin; Christopher Yeh; Cem Atillasoy; Christine Marshall; Tzvete Dentchev; Todd Ridky; John T Seykora
Journal:  Exp Dermatol       Date:  2019-10-29       Impact factor: 3.960

4.  High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients.

Authors:  Jonathan P Singer; Andreas Boker; Christopher Metchnikoff; Maxwell Binstock; Rebecca Boettger; Jeffrey A Golden; David V Glidden; Sarah T Arron
Journal:  J Heart Lung Transplant       Date:  2012-04-06       Impact factor: 10.247

5.  Voriconazole N-oxide and its ultraviolet B photoproduct sensitize keratinocytes to ultraviolet A.

Authors:  K Ona; D H Oh
Journal:  Br J Dermatol       Date:  2015-07-20       Impact factor: 9.302

6.  Recurrent and metastatic squamous cell carcinoma in lung transplant recipient on voriconazole: Lessons learned.

Authors:  Shali Zhang; David C Neujahr; Fiona O Zwald
Journal:  JAAD Case Rep       Date:  2015-11-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.